Yahoo Web Search

Search results

1. • 

     Nail Psoriasis

     Health via Yahoo News· 6 days ago

     Nail psoriasis is generally not a standalone condition—it’s caused by psoriasis or psoriatic arthritis. People might develop nail psoriasis before they...

2. • 

     6 Signs of an Autoimmune Disease That Can Be Easy to Miss

     Self via Yahoo News· 6 days ago

     A few other notable autoimmune conditions that can cause joint issues? Lupus (one type that attacks...

3. • 

     What To Know and Do About Arthritis Pain

     Health via Yahoo News· 5 days ago

     Arthritis is a condition that causes pain, stiffness, and inflammation in your joints. Fortunately, medications and home remedies can help relieve pain.

4. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. -...

     Benzinga· 3 days ago

     "We are proud to make SIMLANDI available in the U.S. to patients and providers," said Thomas...

5. • 

     Research shows linked biological pathways driving skin inflammation

     Medical Xpress· 3 days ago

     Inflammation is the body's natural response to irritation and infection, but when out of control, it...

6. • AltruBio, after tweaking checkpoint drug, raises $225M for midphase ulcerative colitis program

     FierceBiotech· 2 days ago

     AltruBio has roared back after another pivot in its twisty history, securing up to $225 million in series B funding to take an immune checkpoint enhancer through a midphase ulcerative colitis ...

7. • AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...

     Tri-County Times· 6 days ago

     - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)

8. • 

     Imported Drugs: (Possibly) Coming Soon to a State Near You

     The National Law Review· 7 days ago

     As we previously discussed, the US Department of Health and Human Services (HHS) issued a final rule...

9. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

     FOX 23 News Albany· 3 days ago

     WASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...